Misplaced Pages

Enkephalinases are enzymes that degrade endogenous enkephalin opioid peptides. They include:

• Aminopeptidase N (APN)
• Neutral endopeptidase (NEP)
• Dipeptidyl peptidase 3 (DPP3)
• Carboxypeptidase A6 (CPA6)
• Leucyl/cystinyl aminopeptidase (LNPEP)
• Angiotensin-converting enzyme (ACE)

See also

• Enkephalinase inhibitor
• Oxytocinase

References

1. ^ Thanawala V, Kadam VJ, Ghosh R (October 2008). "Enkephalinase inhibitors: potential agents for the management of pain". Current Drug Targets. 9 (10): 887–94. doi:10.2174/138945008785909356. PMID 18855623. Archived from the original on 2013-04-14.{{cite journal}}: CS1 maint: unfit URL (link)
2. Lyons PJ, Callaway MB, Fricker LD (March 2008). "Characterization of carboxypeptidase A6, an extracellular matrix peptidase". The Journal of Biological Chemistry. 283 (11): 7054–63. doi:10.1074/jbc.M707680200. PMID 18178555.
3. Benuck M, Berg MJ, Marks N (1982). "Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes". Neurochemistry International. 4 (5): 389–96. doi:10.1016/0197-0186(82)90081-X. PMID 20487892. S2CID 23138078.

This enzyme-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Hydrolases
• Human proteins
• Nociception
• Enzyme stubs